Avatar of Smith

Independent Clinical Laboratory Market: 2017 China Industry Trends, Share, Size and 2021 Forecasts Report

0 rating, 0 votes0 rating, 0 votes (0 rating, 0 votes, rated)
You need to be a registered member to rate this post.
Loading ... Loading ...

August 7, 2017 in Health


Independent Clinical Laboratory Market Report is a comprehensive business research report that highlights the latest business trends with a thorough description for each and every business aspect of the Independent Clinical Laboratory industry.

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States and Japan. Furthermore, Chinese independent clinical laboratories can provide more than 2,000 test items, while the counterparts in the United States can offer over 4,000 test items.

Companies Mentioned: KingMed Diagnostics, DIAN Diagnostics , Shanghai Labway Clinical Laboratory , DAAN Gene , ADICON Clinical Laboratories, NYMPHAVN Biotechnology , SurExam Biotechnology, MedicalSystem Biotechnology , Beijing Lawke Health Laboratory, Beijing Lepu Gene Technology , Shanghai Biotecan Pharmaceuticals, Jiangsu Superbio Life Science, Amoy Diagnostics, Guangdong Hybribio Biotech , Other Enterprises.

Get Discount on this Research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1150508

However, China's independent clinical laboratory industry is progressing rapidly, presenting the CAGR of 41.4% during 2010-2016, with the market size reaching RMB9.6 billion (an upsurge of 37.1% year on year) in 2016.

Pushed by the promotion of hierarchical medical system and other favorable policies, the growth of the outsourcing demand from public and private hospitals under the pressure of cost control, the acceleration of population aging as well as the people's ever growing awareness of health, etc., the independent clinical laboratory market size in China will maintain growth rate of at least 30% in the next five years and reach RMB41.4 billion by 2021.

As of the end of 2016, there had been 468 independent clinical laboratories in China, an increase of 112 ones over the same period of last year. They were mainly distributed in the developed coastal areas, about 50% of which were located in Shanghai, Beijing, Guangdong, Zhejiang and Jiangsu.

At present, major independent clinical laboratory companies in China include KingMed Diagnostics, ADICON, DIAN Diagnostics, DAAN Gene, Shanghai Labway Clinical Laboraory, MedicalSystem Biotechnology, Beijing Lepu Gene Technology and so forth. With cutting-edge advantages in the number of laboratories and inspection items which directly demonstrate the competitiveness of enterprises, KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene held a combined market share of over 70% in 2016. In the future, leading enterprises will continue to accelerate the chain-based expansion of laboratory network nationwide, further enhance their competitiveness, and intensify the market concentration.

Direct Purchase of this research report at http://www.reportsnreports.com/purchase.aspx?name=1150508

Table of Contents

1. Overview of Independent Clinical Laboratory

2. Overview of China Independent Clinical Laboratory Industry

3. Upstream and Downstream Sectors of China Independent Clinical Laboratory Industry

4. Key Players

List of Charts

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading China publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. Feel free to Call us at + 1 888 391 5441 or Email us at sales@reportsandreports.com

Infowars.com Videos:

Comment on this article:

Leave a reply

You must be logged in to post a comment.